Growing community of inventors

San Diego, CA, United States of America

Rohit Kumar Duvadie

Average Co-Inventor Count = 3.16

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 13

Rohit Kumar DuvadieYi Yang (2 patents)Rohit Kumar DuvadieShao Song Chu (2 patents)Rohit Kumar DuvadieWesley Kwan Mung Chong (2 patents)Rohit Kumar DuvadieLin Li (2 patents)Rohit Kumar DuvadieMichael Brennan Wallace (1 patent)Rohit Kumar DuvadieSiegfried Heinz Reich (1 patent)Rohit Kumar DuvadieWei Xiao (1 patent)Rohit Kumar DuvadieTed Michael Bleckman (1 patent)Rohit Kumar DuvadieWilliam Henry Romines, Iii (1 patent)Rohit Kumar DuvadieWesley K M Chong (1 patent)Rohit Kumar DuvadieLarry Andrew Alegria (1 patent)Rohit Kumar DuvadieWesley Kwon Mung Chong (1 patent)Rohit Kumar DuvadieRohit Kumar Duvadie (4 patents)Yi YangYi Yang (11 patents)Shao Song ChuShao Song Chu (5 patents)Wesley Kwan Mung ChongWesley Kwan Mung Chong (5 patents)Lin LiLin Li (3 patents)Michael Brennan WallaceMichael Brennan Wallace (94 patents)Siegfried Heinz ReichSiegfried Heinz Reich (50 patents)Wei XiaoWei Xiao (21 patents)Ted Michael BleckmanTed Michael Bleckman (11 patents)William Henry Romines, IiiWilliam Henry Romines, Iii (8 patents)Wesley K M ChongWesley K M Chong (4 patents)Larry Andrew AlegriaLarry Andrew Alegria (2 patents)Wesley Kwon Mung ChongWesley Kwon Mung Chong (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Agouron Pharmaceuticals, Inc. (4 from 174 patents)


4 patents:

1. 6720346 - Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation

2. 6569878 - Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors

3. 6566363 - Pyrazole-thiazole compounds, pharmaceutical compositions containing them

4. 6462060 - Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…